Sociodemographic Predictors of Missed Appointments Among Patients With Cleft Lip and Palate

Jeremy V Lynn1, Kavitha Ranganathan2, Matthew H Bageris1

  • 11 Craniofacial Research Laboratory, Section of Plastic and Reconstructive Surgery, University of Michigan, Ann Arbor, MI, USA.

Insights

Disparities in cleft lip and/or palate (CL/P) care exist, with certain sociodemographic factors increasing missed appointments. Identifying at-risk patients is crucial for improving care quality and resource allocation.

Area of Science:

  • Health Services Research
  • Pediatric Surgery
  • Health Disparities

Background:

  • Cleft lip and/or palate (CL/P) treatment requires consistent patient adherence to a multidisciplinary care schedule.
  • Sociodemographic factors may influence appointment compliance and impact overall patient outcomes.

Purpose of the Study:

  • To identify disparities in cleft lip and/or palate (CL/P) care by examining the impact of sociodemographic variables on missed appointments and Child Protective Services (CPS) involvement.
  • To determine if specific patient populations are at higher risk for non-adherence to scheduled care.

Main Methods:

  • A retrospective, noninterventional quality assessment study analyzed data from 178 patients with CL/P treated between 2011 and 2014.
  • Missed appointments were calculated as a percentage of total scheduled appointments from diagnosis to data collection.
  • Statistical analysis identified sociodemographic predictors of missed appointments and CPS involvement.

Main Results:

  • The overall rate of missed appointments was 9.6%, with 66.8% of patients missing at least one visit.
  • Patients who were Black, not affiliated with a religion, Medicaid users, from unstable social backgrounds, or receiving financial assistance were significantly more likely to miss appointments.
  • Child Protective Services (CPS) involvement was noted in 3.9% of patients.

Conclusions:

  • Significant disparities in appointment attendance exist among patients with CL/P.
  • At-risk patient populations, defined by specific sociodemographic characteristics, have been identified.
  • Efficient planning and allocation of cleft care resources are necessary to enhance care quality for vulnerable individuals.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334